Shares of Billiontoone, Inc. (NASDAQ:BLLN – Get Free Report) gapped down before the market opened on Thursday following insider selling activity. Billiontoone shares last traded at $94.4910, with a volume of 803,215 shares traded. Benzinga analyst price target reportBTIG Research maintained a rating while lowering its price target from $142 to $130. Billiontoone Price PerformanceThe company has a 50-day moving average of $116.73 and a 200 day moving average of $94.26. Billiontoone Company Profile(Get Free Report)BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology.